Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Volker Kunzmann & Martin Wilhelm. (2005) Anti-lymphoma effect of γδ T cells. Leukemia & Lymphoma 46:5, pages 671-680.
Read now
Read now
Articles from other publishers (44)
Afsheen Raza, Reyad Mohsen, Aladdin Kanbour, Abdul Rehman Zar Gul, Anite Philip, Suma Vijayakumar, Shereena Hydrose, Kirti S. Prabhu, Aisha Khamis Al-Suwaidi, Varghese Philipose Inchakalody, Maysaloun Merhi, Dina M. Abo El-Ella, Melissa Annrose Tauro, Shayista Akbar, Issam Al-Bozom, Wafa Abualainin, Rajaa Al-Abdulla, Shaza Abu Sirriya, Suparna Hassnad, Shahab Uddin, Mohamed Izham Mohamed Ibrahim, Ussama Al Homsi & Said Demime. (2023) Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression. Frontiers in Immunology 14.
Crossref
Crossref
Amber B. Jones, Abbey Rocco, Lawrence S. Lamb, Gregory K. Friedman & Anita B. Hjelmeland. (2022) Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression. Cancers 14:9, pages 2339.
Crossref
Crossref
Simon Jasinski-Bergner, Ofer Mandelboim & Barbara Seliger. (2020) Molecular mechanisms of human herpes viruses inferring with host immune surveillance. Journal for ImmunoTherapy of Cancer 8:2, pages e000841.
Crossref
Crossref
Tobias Zöller, Mareike Wittenbrink, Meike Hoffmeister & Alexander Steinle. (2018) Cutting an NKG2D Ligand Short: Cellular Processing of the Peculiar Human NKG2D Ligand ULBP4. Frontiers in Immunology 9.
Crossref
Crossref
Yuanji Xu, Lin Zhou, Jingfeng Zong, Yunbin Ye, Gang Chen, Yanping Chen, Xuehong Liao, Qiaojuan Guo, Sufang Qiu, Shaojun Lin, Honglin Chen & Jianji Pan. (2017) Decreased expression of the NKG2D ligand ULBP4 may be an indicator of poor prognosis in patients with nasopharyngeal carcinoma. Oncotarget 8:26, pages 42007-42019.
Crossref
Crossref
Stephanie C. Casey, Amedeo Amedei, Katia Aquilano, Asfar S. Azmi, Fabian Benencia, Dipita Bhakta, Alan E. Bilsland, Chandra S. Boosani, Sophie Chen, Maria Rosa Ciriolo, Sarah Crawford, Hiromasa Fujii, Alexandros G. Georgakilas, Gunjan Guha, Dorota Halicka, William G. Helferich, Petr Heneberg, Kanya Honoki, W. Nicol Keith, Sid P. Kerkar, Sulma I. Mohammed, Elena Niccolai, Somaira Nowsheen, H.P. Vasantha Rupasinghe, Abbas Samadi, Neetu Singh, Wamidh H. Talib, Vasundara Venkateswaran, Richard L. Whelan, Xujuan Yang & Dean W. Felsher. (2015) Cancer prevention and therapy through the modulation of the tumor microenvironment. Seminars in Cancer Biology 35, pages S199-S223.
Crossref
Crossref
Raphael Carapito & Seiamak Bahram. (2015) Genetics, genomics, and evolutionary biology of NKG2D ligands. Immunological Reviews 267:1, pages 88-116.
Crossref
Crossref
YEBIN LU, JUANJUAN HU, WEIJIA SUN, XIAOHUI DUAN & XIONG CHEN. (2015) Hypoxia-mediated immune evasion of pancreatic carcinoma cells. Molecular Medicine Reports 11:5, pages 3666-3672.
Crossref
Crossref
Zhu Zeng, Xiaofeng Xu & Dan ChenZhu Zeng, Xiaofeng Xu & Dan Chen. 2015. Dendritic Cells: Biophysics, Tumor Microenvironment and Chinese Traditional Medicine. Dendritic Cells: Biophysics, Tumor Microenvironment and Chinese Traditional Medicine
55
63
.
YEBIN LU, JUANJUAN HU, WEIJIA SUN, XIAOHUI DUAN & XIONG CHEN. (2014) Nitric oxide signaling pathway activation inhibits the immune escape of pancreatic carcinoma cells. Oncology Letters 8:6, pages 2371-2378.
Crossref
Crossref
Simon Jasinski-Bergner, Ofer Mandelboim & Barbara Seliger. (2014) The Role of MicroRNAs in the Control of Innate Immune Response in Cancer. JNCI: Journal of the National Cancer Institute 106:10.
Crossref
Crossref
Wei-Hong Sha, Xiao-Hui Zeng & Lu Min. (2014) The Correlation between NK Cell and Liver Function in Patients with Primary Hepatocellular Carcinoma. Gut and Liver 8:3, pages 298-305.
Crossref
Crossref
Charlotte M. Vines. 2014. Phospholipases in Health and Disease. Phospholipases in Health and Disease
211
226
.
Miriam I Jimenez-Perez, Luis F Jave-Suarez, Pablo C Ortiz-Lazareno, Alejandro Bravo-Cuellar, Oscar Gonzalez-Ramella, Adriana Aguilar-Lemarroy, Georgina Hernandez-Flores, Ana L Pereira-Suarez, Adrian Daneri-Navarro & Susana del Toro-Arreola. (2012) Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications. BMC Immunology 13:1.
Crossref
Crossref
Fabian Benencia, Leslee Sprague, John McGinty, Michelle Pate & Maria Muccioli. (2012) Dendritic Cells The Tumor Microenvironment and the Challenges for an Effective Antitumor Vaccination. Journal of Biomedicine and Biotechnology 2012, pages 1-15.
Crossref
Crossref
Hiroaki Saito, Tomohiro Osaki & Masahide Ikeguchi. (2011) Decreased NKG2D expression on NK cells correlates with impaired NK cell function in patients with gastric cancer. Gastric Cancer 15:1, pages 27-33.
Crossref
Crossref
Min Cheng, Juan Ma, Yongyan Chen, Jianhua Zhang, Weidong Zhao, Jian Zhang, Haiming Wei, Bin Ling, Rui Sun & Zhigang Tian. (2011) Establishment, Characterization, and Successful Adaptive Therapy against Human Tumors of NKG Cell, a New Human NK Cell Line. Cell Transplantation 20:11-12, pages 1731-1746.
Crossref
Crossref
Xiulong Xu, Geetha S Rao, Veronika Groh, Thomas Spies, Paolo Gattuso, Howard L Kaufman, Janet Plate & Richard A Prinz. (2011) Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: Role of uric acid accumulation in gemcitabine-induced MICA/B expression. BMC Cancer 11:1.
Crossref
Crossref
Amorette Barber & Charles L. Sentman. (2011) NKG2D receptor regulates human effector T-cell cytokine production. Blood 117:24, pages 6571-6581.
Crossref
Crossref
Eric Champagne. (2011) γδ T cell Receptor Ligands and Modes of Antigen Recognition. Archivum Immunologiae et Therapiae Experimentalis 59:2, pages 117-137.
Crossref
Crossref
Jennifer AA Gubbels, Nick Claussen, Arvinder K Kapur, Joseph P Connor & Manish S Patankar. (2010) The detection, treatment, and biology of epithelial ovarian cancer. Journal of Ovarian Research 3:1.
Crossref
Crossref
Kamalakannan Rajasekaran, Va Xiong, Lee Fong, Jack Gorski & Subramaniam Malarkannan. (2010) Functional Dichotomy between NKG2D and CD28-Mediated Co-Stimulation in Human CD8+ T Cells. PLoS ONE 5:9, pages e12635.
Crossref
Crossref
Yan Kong, Wei Cao, Xueyan Xi, Chi Ma, Lianxian Cui & Wei He. (2009) The NKG2D ligand ULBP4 binds to TCRγ9/δ2 and induces cytotoxicity to tumor cells through both TCRγδ and NKG2D. Blood 114:2, pages 310-317.
Crossref
Crossref
Mareike Wittenbrink, Jessica Spreu & Alexander Steinle. (2009) Differential NKG2D binding to highly related human NKG2D ligands ULBP2 and RAET1G is determined by a single amino acid in the α2 domain. European Journal of Immunology 39:6, pages 1642-1651.
Crossref
Crossref
Fabian Benencia, Maria C Courrèges & George Coukos. (2008) Whole tumor antigen vaccination using dendritic cells: Comparison of RNA electroporation and pulsing with UV-irradiated tumor cells. Journal of Translational Medicine 6:1.
Crossref
Crossref
Wei Cao, Xueyan Xi, Zhun Wang, Liling Dong, Zhiyong Hao, Lianxian Cui, Chi Ma & Wei He. (2008) Four novel ULBP splice variants are ligands for human NKG2D. International Immunology 20:8, pages 981-991.
Crossref
Crossref
George Coukos, Ioannis Alagkiozidis, Sarah Kim, Mark Cadungog, Sarah Adams, Christina Chu, Jos? Conejo-Garcia, Weiping Zou, Tyler Curiel, Dionysios Katsaros, Lin Zhang & Phyllis Gimotty. 2007. Prognostic and Predictive Factors in Gynecologic Cancers. Prognostic and Predictive Factors in Gynecologic Cancers
125
139
.
Robert A. Eagle & John Trowsdale. (2007) Promiscuity and the single receptor: NKG2D. Nature Reviews Immunology 7:9, pages 737-744.
Crossref
Crossref
Anita R. Mistry & Chris A. O'Callaghan. (2007) Regulation of ligands for the activating receptor NKG2D. Immunology 121:4, pages 439-447.
Crossref
Crossref
Amorette Barber, Tong Zhang, Leslie R. DeMars, Jose Conejo-Garcia, Katherine F. Roby & Charles L. Sentman. (2007) Chimeric NKG2D Receptor–Bearing T Cells as Immunotherapy for Ovarian Cancer. Cancer Research 67:10, pages 5003-5008.
Crossref
Crossref
J?r?me D. Coudert & Werner Held. (2006) The role of the NKG2D receptor for tumor immunity. Seminars in Cancer Biology 16:5, pages 333-343.
Crossref
Crossref
Jadee L. Upshaw & Paul J. Leibson. (2006) NKG2D-mediated activation of cytotoxic lymphocytes: Unique signaling pathways and distinct functional outcomes. Seminars in Immunology 18:3, pages 167-175.
Crossref
Crossref
Mark J. Smyth, Gavin P. Dunn & Robert D. Schreiber. 2006. Cancer Immunotherapy. Cancer Immunotherapy
1
50
.
Yoshihiro Hayakawa & Mark J. Smyth. 2006.
293
322
.
Charles L. Sentman, Melissa A. Barber, Amorette Barber & Tong Zhang. 2006.
249
292
.
Harald Wajant. 2006. The Link Between Inflammation and Cancer. The Link Between Inflammation and Cancer
141
165
.
Fabian Benencia, Maria C. Courr?ges, Jos? R. Conejo-Garc?a, Alisha Mohamed-Hadley, Lin Zhang, Ronald J. Buckanovich, Richard Carroll, Nigel Fraser & George Coukos. (2005) HSV oncolytic therapy upregulates interferon-inducible chemokines and recruits immune effector cells in ovarian cancer. Molecular Therapy 12:5, pages 789-802.
Crossref
Crossref
Mary A. Markiewicz, Leonidas N. Carayannopoulos, Olga V. Naidenko, Ken Matsui, W. Richard Burack, Erica L. Wise, Daved H. Fremont, Paul M. Allen, Wayne M. Yokoyama, Marco Colonna & Andrey S. Shaw. (2005) Costimulation through NKG2D Enhances Murine CD8+ CTL Function: Similarities and Differences between NKG2D and CD28 Costimulation. The Journal of Immunology 175:5, pages 2825-2833.
Crossref
Crossref
Wei Cao & Wei He. (2004) UL16 binding proteins. Immunobiology 209:3, pages 283-290.
Crossref
Crossref
Jennifer D. Wu, Lily M. Higgins, Alexander Steinle, David Cosman, Kathy Haugk & Stephen R. Plymate. (2004) Prevalent expression of the immunostimulatory MHC class I chain?related molecule is counteracted by shedding in prostate cancer. Journal of Clinical Investigation 114:4, pages 560-568.
Crossref
Crossref
Jukka Vakkila & Michael T. Lotze. (2004) Inflammation and necrosis promote tumour growth. Nature Reviews Immunology 4:8, pages 641-648.
Crossref
Crossref
Gavin P. Dunn, Lloyd J. Old & Robert D. Schreiber. (2004) The Immunobiology of Cancer Immunosurveillance and Immunoediting. Immunity 21:2, pages 137-148.
Crossref
Crossref
Jose R. Conejo-Garcia, Fabian Benencia, Maria C. Courreges, Phyllis A. Gimotty, Eugene Khang, Ronald J. Buckanovich, Kenneth A. Frauwirth, Lin Zhang, Dionyssios Katsaros, Craig B. Thompson, Bruce Levine & George Coukos. (2004) Ovarian Carcinoma Expresses the NKG2D Ligand Letal and Promotes the Survival and Expansion of CD28− Antitumor T Cells. Cancer Research 64:6, pages 2175-2182.
Crossref
Crossref
Michael T. Lotze & Ronald B. Herberman. 2004. Cancer and Inflammation. Cancer and Inflammation
21
51
.